Company
Xenon Pharmaceuticals Inc.
Open roles
2
Functions
Marketing & Sales, Healthcare & Medical
Hiring for
the United States
Open to any country
0 of 2
Pay disclosed
0 of 2
Newest posting
2d ago
Director, Strategic Engagements (Northeast)2d ago
USA
Senior Director, Field Access2d ago
USA
Browse similar roles across all companiesthe United States remote jobs
About working at Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. is hiring for 2 live remote roles right now, listed on RemoShift and refreshed from Jobicy. The openings span Marketing & Sales, Healthcare & Medical work, with roles open to candidates in the USA.
Every listing on this page links to the original posting โ we don't host applications, so apply directly on Xenon Pharmaceuticals Inc.'s own careers page. Roles expire when the employer removes them or age out of the index, so check back often.
Open remote roles
2 live positions
Hiring for
Marketing & Sales, Healthcare & Medical
Open to
the USA
Frequently asked questions
How do I apply for a remote job at Xenon Pharmaceuticals Inc.?
Each listing on this page links to the original posting on Xenon Pharmaceuticals Inc.'s site. Click "Apply on original site" on the job card to go directly to the application โ we don't host or process applications, so the employer sees your application in full.
Where are Xenon Pharmaceuticals Inc.'s remote roles open?
The live openings are open to candidates in the USA, though specific roles may carry their own location or timezone requirements stated on the original posting.
How current is this Xenon Pharmaceuticals Inc. jobs list?
RemoShift refreshes Jobicy every 30 minutes, so this list reflects what Xenon Pharmaceuticals Inc. is hiring for right now. Posts stay live until the employer removes them or they age out of the index.
New jobs at Xenon Pharmaceuticals Inc. โ by email
Daily email, only when there's something new. One click to stop.
More roles like Xenon Pharmaceuticals Inc., weekly.
One digest on Monday โ the best new remote jobs. No spam, unsubscribe anytime.